China Hypertension and Diabetes Care Cascade Study
CHICCs
1 other identifier
interventional
14,400
0 countries
N/A
Brief Summary
This implementation study aims to identify priorities and formulate strategies to overcome health service delivery bottlenecks associated with hypertension and diabetes in rural China. Leveraging implementation frameworks, the study seeks to unravel the complexities embedded within the care cascade, paving the way for targeted interventions. Addressing the nuanced dynamics of the care cascade, this research will provide indispensable insights for optimising healthcare delivery in resource-limited settings, ultimately informing global perspectives on chronic disease management. The overall aim of this study is to enhance the control of hypertension and diabetes in rural China through a systematic assessment and improvement of the care cascade, specifically:
- 1.To describe the cascade gap and identify barriers and facilitators at each cascade stage.
- 2.To develop practical interventions through stakeholder co-design.
- 3.To assess the effectiveness of developed interventions and evaluate implementation strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jan 2024
Typical duration for not_applicable hypertension
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 21, 2023
November 1, 2023
3 years
November 15, 2023
November 15, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Change of blood pressure control at baseline and at 12 month
The proportion of hypertension patients who have achieved BP control. We defined control as BP \< 140/90 mmHg or lower in complex cases, such as diabetes
Baseline and at 12 month
Change of blood glucose control at baseline and at 12 month
The proportion of diabetes patients who have achieved HbA1c \< 6.5%
Baseline and at 12 month
Change of SBP at baseline and at 12 month
Blood pressure is measured after the participant has rested for at least 15 minutes. Blood pressure is measured at least three times at 3 minutes intervals using the appropriate cuff size and a Digital Automatic Blood Pressure Monitor
Baseline and at 12 month
Secondary Outcomes (3)
Screening rate at baseline and at 12 month
Baseline and at 12 month
Diagnosis rate at baseline and at 12 month
Baseline and at 12 month
Treatment rate at baseline and at 12 month
Baseline and at 12 month
Study Arms (2)
Intervention
EXPERIMENTALStakeholder-based participatory research will be conducted after CFIR-ERIC mapping activities to focus on partnerships, engagement, co-learning, and developing interventions incorporating interventions on existing practices. Three workshops will be held to reach agreements on the intervention tools, the implementation structure, the data collection procedures and the study audit process among the research team, local policymakers, and implementers. The participants and contents of each workshop are shown in Table 1. At the end of the workshop series, the implementation team from each county prepared a proposed intervention plan describing the steps needed to achieve their goals within a set timeline. The agreed plan of action considered their constraints and how to overcome those barriers.
Control
NO INTERVENTIONUsual care
Interventions
Co-designed integrated care based on the Chronic Care Model to improve hypertension and diabetes care cascade
Eligibility Criteria
You may qualify if:
- Permanent residents of the surveyed village (residing for more than six months each year).
- Age between 35 and 74 years old.
You may not qualify if:
- Individuals with severe mental disorders or communication barriers.
- Individuals planning to move out of the village within the next year.
- Expected life expectancy of less than one year.
- Pregnant or lactating individuals.
- Individuals who are currently away (i.e. hospitalized, or residing elsewhere) so that cannot participate in the survey.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Yin X, Wang Z, Yang J, Li J, Han S, Feng W, Liu Q, Li N, Zhang L, Ke J, Wei X, Zhang J, Sarrafzadegan N, Shao R. Improvement of Care Cascade for Hypertension and Diabetes in Rural China: Protocol for an Implementation Study. J Clin Hypertens (Greenwich). 2024 Dec;26(12):1466-1478. doi: 10.1111/jch.14918. Epub 2024 Nov 4.
PMID: 39494843DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
November 15, 2023
First Posted
November 21, 2023
Study Start
January 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 21, 2023
Record last verified: 2023-11